Multidisciplinaire richtlijn Polyfarmacie bij ouderen

Translated title of the contribution: Multidisciplinary guideline for polypharmacy in the elderly

Monique Verduijn*, Anne Leendertse, Annemarie Moeselaar, Niek De Wit, Rob Van Marum

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Older (> 65 years) patients who are being treated by different specialists for multiple medical problems are at increased risk of medication-related adverse effects. Unfortunately, little is known about the efficacy and safety of many medicines in these vulnerable patients. General practitioners can limit the risk of adverse effects by following the recommendations of the 'Polypharmacy for the Elderly' guideline and by using the START (Screening Tool to Alert doctors to Right Treatment) and STOPP (Screening Tool of Older Person's Prescriptions) criteria of the guideline. In addition, GPs can work with pharmacists to provide integrated pharmaceutical care by system atically evaluating the medicines prescribed using the stepwise approach of the STRIP (Systematic Tool to Reduce Inappropriate Prescribing). However, a number of preconditions for a good evaluation of medications have still to be met.

Original languageDutch
Pages (from-to)414-419
Number of pages6
JournalHuisarts en Wetenschap
Volume56
Issue number8
DOIs
Publication statusPublished - 1 Aug 2013

Cite this